We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Unifirst Corp
UNF
$5.24B
| $288K | ﹤0.01% |
1,670
-3,233
| -66% | -$540K |
|
1877
Stanley Black & Decker
SWK
$15.5B
| $287K | ﹤0.01% |
2,770
-111,044
| -98% | -$13.7M |
|
1878
Caleres
CAL
$486M
| $286K | ﹤0.01% |
10,901
-21,146
| -66% | -$523K |
|
|
SP
1879
DELISTED
SP Plus Corporation
SP
| $286K | ﹤0.01% |
+9,300
| New | +$281K |
|
1880
Gogo Inc
GOGO
$432M
| $284K | ﹤0.01% |
+17,533
| New | +$334K |
|
1881
Metropolitan Bank Holding Corp
MCB
$1.15B
| $284K | ﹤0.01% |
4,089
-1,533
| -27% | -$127K |
|
|
GATO
1882
DELISTED
Gatos Silver, Inc.
GATO
| $284K | ﹤0.01% |
98,874
+75,613
| +325% | +$266K |
|
1883
ATI
ATI
$31.1B
| $283K | ﹤0.01% |
+12,440
| New | +$328K |
|
1884
Vipshop
VIPS
$7.4B
| $282K | ﹤0.01% |
28,469
+6,689
| +31% | +$58.9K |
|
|
LOVE
1885
LoveSac
LOVE
$253M
| $281K | ﹤0.01% |
10,233
-655
| -6% | -$25.5K |
|
|
RJET
1886
Republic Airways Holdings
RJET
$946M
| $281K | ﹤0.01% |
8,565
+5,509
| +180% | +$259K |
|
1887
Northern Oil and Gas
NOG
$2.56B
| $280K | ﹤0.01% |
11,082
+1,829
| +20% | +$53.1K |
|
1888
ESCO Technologies
ESE
$7.79B
| $279K | ﹤0.01% |
4,086
-3,272
| -44% | -$214K |
|
1889
Southern Missouri Bancorp
SMBC
$842M
| $279K | ﹤0.01% |
6,167
+1,324
| +27% | +$60K |
|
|
RCM
1890
DELISTED
R1 RCM Inc. Common Stock
RCM
| $278K | ﹤0.01% |
13,420
+3,469
| +35% | +$78.7K |
|
|
FSP
1891
Franklin Street Properties
FSP
$45.3M
| $277K | ﹤0.01% |
66,439
+52,818
| +388% | +$253K |
|
1892
Varonis Systems
VRNS
$4.87B
| $277K | ﹤0.01% |
9,458
-18,787
| -67% | -$698K |
|
|
SAVE
1893
DELISTED
Spirit Airlines, Inc.
SAVE
| $277K | ﹤0.01% |
11,599
-6,309
| -35% | -$140K |
|
1894
H.B. Fuller
FUL
$3.29B
| $275K | ﹤0.01% |
4,568
-7
| -0.2% | -$469 |
|
|
KE
1895
Kimball Electronics
KE
$605M
| $274K | ﹤0.01% |
13,654
-18,311
| -57% | -$345K |
|
1896
Southside Bancshares
SBSI
$953M
| $273K | ﹤0.01% |
7,303
-6,581
| -47% | -$256K |
|
1897
Napco Security Technologies
NSSC
$1.43B
| $270K | ﹤0.01% |
13,102
+1,209
| +10% | +$22.7K |
|
1898
BrightView Holdings
BV
$1.05B
| $269K | ﹤0.01% |
+22,376
| New | +$280K |
|
1899
Target Hospitality
TH
$1.6B
| $269K | ﹤0.01% |
47,188
+8,515
| +22% | +$53.3K |
|
1900
Cullinan Oncology
CGEM
$1.18B
| $268K | ﹤0.01% |
+20,909
| New | +$237K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.